MedPath

Effect of Foxtail Millet Powder WithLow Salts In Stage 3 Chronic Kidney Disease patients

Phase 3
Conditions
Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)
Registration Number
CTRI/2023/10/058181
Lead Sponsor
BR Medical Research and software solutions OPC Private limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Willing and able to provide written informed consent prior to

performing study procedures.

2. Patients between the age of 45 to 65 years, male or female.

3. Patients in stage III CKD and who are on salt restricted diet and

able to drink 350 ml/day.

4. Females must be non-pregnant / non-lactating and practicing

adequate birth control measures if not menopausal.

5. Patient should have not participated in any other clinical trial

during the past 3 months.

Exclusion Criteria

1. Patient who are unable to consume solid and liquid orals.

2. Having active infection

3. Very high level of creatinine ( >4 mg/dl).

4. Hypersensitivity to test product.

5. History of drug or alcohol abuse.

6. Consideration by the investigator, for any reason, that the

subject is an unsuitable candidate to receive study treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Each patient will be monitored for any adverse drug reaction. <br/ ><br>Other Safety parameters includes monitoring for any change <br/ ><br>in the blood parameters. <br/ ><br> <br/ ><br>2) Other parameters monitored include; Nausea, Vomiting, <br/ ><br>Gastritis, ability to consume 350 ml, skin reaction, able to <br/ ><br>pass stool comfortably, any event of hypoglycemic in <br/ ><br>diabetic patient, palpitation, hypertensive or hypotensive <br/ ><br>episodes and weight gain or loss.Timepoint: Day 0, Day 7, Day 15
Secondary Outcome Measures
NameTimeMethod
To monitor for any changes in any of the Laboratory parameters pre <br/ ><br>and post study.Timepoint: Day 0, Day 7, Day 15
© Copyright 2025. All Rights Reserved by MedPath